Ampalayohan, Baby Gilr .

HRN: 28-84-80  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/20/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/20/2026
04/27/2026
IV
37mg
Q24H
PSNB (PROMx 36H)
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: